Search for: "US v. Smith" Results 2081 - 2100 of 9,458
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
31 Oct 2019, 3:22 pm by Giles Peaker
In particular, I consider the defendant erred in failing properly to consider the submission that the use of Grade A fee-earners for the majority of the work was unreasonable. [read post]
29 Oct 2019, 12:47 pm by Ilya Somin
But California's position was greatly strengthened by the Supreme Court's May 2018 ruling in Murphy v. [read post]
28 Oct 2019, 4:00 am by Josh Blackman
Part V: The Separation of Powers Every casebook included Morrison v. [read post]
11 Oct 2019, 7:12 am by Jay Pinho
Smith National Library for the Study of George Washington at Mount Vernon. [read post]
Notably, CMS and OIG propose to expressly exclude, or are seeking comments regarding whether to exclude, certain entities from participating in protected arrangements on the basis of historical enforcement and oversight experience: (i) pharmaceutical manufacturers; (ii) manufacturers, distributors, or suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS); (iii) laboratories; (iv) pharmacy benefit managers; and (v) other wholesalers and distributors. [read post]
8 Oct 2019, 9:59 pm by Patent Docs
Noonan -- Last week, the Federal Circuit overturned an obviousness determination in an inter partes review by the Patent Trial and Appeal Board in OSI Pharmaceuticals LLC v. [read post]
8 Oct 2019, 5:54 am by Phil Dixon
Further, these actions were reasonable under the factors in Brown v. [read post]